Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

GRIP1 Kit CLIA

Ce kit ELISA Chemiluminescent est destiné à la mesure quantitative de Humain GRIP1.
N° du produit ABIN6204707
1.290,21 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 7 à 15 jours ouvrables

Aperçu rapide pour GRIP1 Kit CLIA (ABIN6204707)

Antigène

Voir toutes GRIP1 Kits CLIA
GRIP1 (Glutamate Receptor Interacting Protein 1 (GRIP1))

Reactivité

  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Méthode de détection

Chemiluminescent

Type de méthode

Sandwich ELISA

Gamme de detection

0.312 ng/mL - 20 ng/mL

Application

ELISA

Type d'échantillon

Cell Lysate, Tissue Homogenate
  • Seuil minimal de détection

    0.312 ng/mL

    Fonction

    Human GRIP1 CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates, cell lysates and other biological fluids.

    Analytical Method

    Quantitative

    Sensibilité

    < 0.118 ng/mL
  • Indications d'application

    Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

    Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

    Standard Form: Lyophilized

    Plaque

    Pre-coated

    Restrictions

    For Research Use only
  • Stock

    4 °C/-20 °C

    Stockage commentaire

    Upon receipt, store the kit according to the storage instruction in the kit's manual.

    Date de péremption

    6 months
  • Antigène Voir toutes GRIP1 Kits CLIA

    GRIP1 (Glutamate Receptor Interacting Protein 1 (GRIP1))

    Autre désignation

    Glutamate Receptor Interacting Protein 1

    Pathways

    Intracellular Steroid Hormone Receptor Signaling Pathway
Vous êtes ici:
Chat with us!